Generally, circulating leptin concentrations are higher in obesity and metabolic syndromes, including type 2 diabetes, hypertension, or dyslipidemia, in conjunction with a decrease in adiponectin levels in the blood [20]. This evidence concerns the gene LEP and type 2 diabetes mellitus.